The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Amid wellness craze, FDA weighs lifting peptide restrictions Is BPC 157 Banned? Oral vs. Injectable Forms Explained The Peptide Gamble: A Doctor's Warning on BPC 157 and TB 500 FDA to Consider Lifting Restrictions on Numerous Compounded Peptides Foley & Lardner